Inside Omada's $68M Digital Health Empire

Key Concepts

Omada Health: A virtual-first healthcare provider focused on chronic and cardiometabolic conditions.
Virtual-First Model: Care delivered primarily through digital channels, complementing in-person visits.
Behavior Change: The core methodology used by Omada to address chronic diseases.
Enterprise Model: Omada's solutions are reimbursed by employers, health plans, and government-sponsored plans, not directly by consumers.
Between-Visit Care: Providing continuous support and engagement for patients between their traditional doctor appointments.
Clinical Validation: Rigorous research and peer-reviewed publications demonstrating the effectiveness of Omada's programs.
ROI (Return on Investment): Demonstrating economic benefits and cost savings for payers.
GLP-1 Care Track: A specific program designed to support individuals using GLP-1 medications.
PBMs (Pharmacy Benefit Managers): Key partners in the healthcare ecosystem, involved in managing prescription drug benefits.
Operating Leverage: The ability of a business to increase profits at a faster rate than revenues.
AI (Artificial Intelligence): Increasingly integrated into Omada's platform for member-facing capabilities and care team support.
Hardware Integration: Seamless integration of connected devices (scales, blood pressure cuffs, glucometers) into the care model.
Values-Driven Organization: Emphasizing core behaviors and principles to foster a positive company culture.

Omada Health: A Virtual-First Approach to Chronic Disease Management

This summary details a conversation with Shawn Duffy, CEO of Omada Health, a rapidly growing virtual-first healthcare provider specializing in chronic and cardiometabolic conditions like diabetes and hypertension. The discussion highlights Omada's unique approach to behavior change, its enterprise-focused business model, recent financial successes, and its strategy for future growth and impact on the American healthcare system.

The Genesis of Omada Health and its Differentiated Model

Shawn Duffy founded Omada Health while in medical school, recognizing a significant gap in how chronic diseases were managed. He observed that the traditional healthcare system's visit-based approach, often limited to prescribing medication and scheduling follow-ups months later, was fundamentally ill-suited for conditions requiring daily support and proactive engagement. This led to the creation of Omada's virtual-first model, which emphasizes "between-visit care" and a focus on clinically validated behavior change.

A key differentiator for Omada is its enterprise model. Unlike direct-to-consumer digital health companies, Omada's solutions are reimbursed by employers (self-insured and fully insured), health plans, and government-sponsored plans. This approach, Duffy argues, leads to a less noisy market, greater customer stickiness, and higher retention rates. The revenue model relies on demonstrating clinical and economic outcomes through 30 peer-reviewed publications to these payers, who then reimburse Omada when a member enrolls. This creates solid customer cohorts and revenue visibility.

Member Growth and Revenue Engine

As of the third quarter of 2025, Omada reported 831,000 active members, representing a 53% year-over-year growth. Each "member" is defined as someone actively under Omada's care and support. This member growth directly translates to revenue growth, as a monthly fee, inclusive of care teams, hardware, and all services, is charged per member. These members are not self-paying; their insurance designs cover Omada's services. The primary payers include:

Self-insured employers: Companies that bear the direct cost of their employees' healthcare.
Fully insured health plans: Where the health plan directly pays claims.
Government-sponsored plans: Such as Medicare Advantage.

Omada has well over 2,000 customers as of June 30, 2025, serving as the financial sponsors for its member base.

The revenue model is tied to engagement. For conditions like musculoskeletal issues, if a member uses the service for a few months and feels better, Omada would not charge for the period of disengagement. However, for chronic conditions like obesity, diabetes, and hypertension, members tend to have longer-term needs. Omada has observed that after 12 months, over 55% of members remain engaged monthly, and this figure stays above 50% at 24 months, indicating that the service becomes an integrated part of their daily rhythm and care plan.

Market Opportunity and Prioritization

Omada targets enormous end markets, with over 156 million Americans suffering from chronic conditions, and 40% of adults having two or more. Diabetes alone accounted for one in every seven dollars spent in 2022. The total addressable market (TAM) for pre-diabetes, diabetes, hypertension, and musculoskeletal (MSK) conditions exceeds $100 billion.

Omada began with pre-diabetes and obesity, expanding to diabetes and hypertension around 2019, followed by MSK care. This expansion was driven by customer preference for a platform company that could support multiple clinical needs within their "between-visit" care rubric, rather than solely seeking new market opportunities. The explicit mission of Omada is to "bend the curve" of disease incidence and trends, aiming for a future where epidemiologists observe a positive shift in disease trends attributable to their interventions.

The "Between-Visit" Care Model: Beyond Pamphlets

Duffy emphasizes that Omada is the "anti-pamphlet" approach to healthcare. Instead of providing static information, Omada offers continuous, day-to-day support through a dedicated care model. This model was designed to overcome the limitations of the fee-for-service, visit-by-visit billing system.

The Omada care model complements a member's Primary Care Physician (PCP) and utilizes specialized personnel such as:

Certified Diabetes Education and Care Specialists
Health Coaches
Licensed Clinical Social Workers (LCSWs)
Physical Therapists (for MSK)

This "people meets technology" vision ensures members have someone in their "pocket and in their corner" to address adherence issues, side effects, and other challenges that arise between appointments.

Clinical Validation and Economic Outcomes

Omada views its extensive investment in clinical research as a significant competitive advantage. The company has published 30 peer-reviewed studies covering both clinical and economic outcomes, ranging from observational studies to multi-year, multi-million dollar randomized controlled trials. These data are crucial for convincing sophisticated buyers like health plans, who employ medical experts and actuaries.

Omada's publications demonstrate a potential ROI of approximately 3 to 6x based on gross savings over three years, depending on the specific program. This evidence of both clinical efficacy and economic benefit is essential for commercial success and differentiation.

Financial Performance and Path to Profitability

Omada reported strong third-quarter results, including $68 million in revenue and achieving a positive adjusted EBITDA of $2 million. Duffy attributes this milestone to the continuation of key strategic trends rather than manufactured profitability.

Two primary operational levers contributed to this success:

Single Product to Multi-Product Expansion: Omada has expanded its offerings from one product (pre-diabetes/obesity) to four. This allows for significant leverage in sales and marketing expenditure, as fewer sales representatives are needed to sell multiple products to existing clients. Over 30% of clients now support more than one product.
GLP-1 Care Track: The increased focus on metabolic disease, particularly with the launch of Omada's GLP-1 care track, has been a significant driver. This program supports individuals on GLP-1 medications, addressing the current market spotlight on these treatments.

Omada views its GLP-1 programs as both a new revenue stream and a member acquisition tool. While the GLP-1 care track is a minority of the member base (over 100,000 members as of September), it often serves as an entry point for employers to then roll out Omada's broader suite of services. This "rising tide lifts all boats" dynamic makes GLP-1 a crucial part of their sales motion.

Addressing Co-morbidities and the Role of GLP-1s

The transcript highlights significant co-morbidities: 74% of people with diabetes also have hypertension, and 58% have diabetes and musculoskeletal conditions. GLP-1 medications are seen as a potential catalyst for addressing these interconnected issues. Omada's role is to maximize the benefits of these medications while mitigating cons, including supporting behavior change around diet and physical activity to prevent muscle loss. While GLP-1s are effective for calorie reduction, they don't inherently address the quality of nutrition or the psychological aspects of weight management, which is where Omada's human-led coaching becomes critical.

Partnerships with PBMs and Competitive Landscape

Omada has found PBMs to be great partners, especially for care services alongside medicines. Express Scripts and CVS Caremark are key partners, with Omada integrated into offerings like Encircle RX and CVS Caremark's point solutions management platform. These partnerships allow employers to leverage existing PBM contracts to deploy Omada's services more easily, simplifying the contracting process.

Operating Leverage and Margin Expansion

Omada boasts 66% gross margins (68% non-GAAP), which is impressive for a hybrid tech-human coaching model. A significant factor in achieving these margins is Omada's proprietary technology investment in its care team platform, built from the ground up to support longitudinal care, unlike traditional EHR systems designed for fee-for-service. This internal platform allows for efficient operations, AI integration, and focused support for members.

Future margin expansion opportunities include:

Continued multi-product support: Different products have varying margin profiles, and expanding offerings benefits overall margins.
Cost efficiencies: Volume discounts on hardware and increased efficiency of care team members.
Increased member engagement: Longer engagement periods generate more revenue on the same cost structure, directly boosting margins. Omada aims for a long-term margin target of north of 70%.

Capital Allocation and Growth Strategy

Post-IPO, Omada maintains a disciplined approach to capital allocation, prioritizing organic growth and R&D. While open to strategic M&A, the company's orientation is primarily organic, given the vastness of the end markets and strong organic growth. The focus on product integration and member experience can sometimes be at odds with M&A, setting a high bar for any potential acquisitions. Investments are made with a view to both immediate and longer-term yield, such as the recent addition of a new prescribing capability, a bet for the 2027 sales cycle.

Measuring User Engagement and Retention

The most critical internal metric for Omada is the percentage of members still leveraging Omada at the end of the year, which is over 55%. Numerous sub-metrics are tracked, including the ability of care teams to build rapport in the early stages of the care experience, recognizing its importance as a first impression. While external benchmarks for enterprise companies are scarce, Omada's engagement curves are considered "incredible" by consumer-focused peers.

Customer retention is exceptionally high, north of 90%. The most common reason for losing a customer is a switch to a health plan with which Omada does not have a relationship.

At the member level, retention is driven by the integrated approach of people, hardware, and software. Omada believes that no single component is sufficient; by building a comprehensive suite of resources (connected scales, content, social communities, tracking apps, one-on-one coaching), they create a "showering of resources and support" that fosters stickiness and retention. This integrated model aims to make members feel they have a "team in their pocket and in their corner."

Addressing Concentration Risk and Regulatory Landscape

Omada acknowledges that revenue concentration with a few large payers and employer contracts is common in enterprise healthcare. While there is consolidation at the contracting entity level (e.g., with PBMs like Sigma and Evernorth, where contracts exceed 50%), this is distinct from the client level, which comprises over 2,000 employers and entities. The company prioritizes end-client satisfaction to ensure ecosystem stability. Recent partnerships with CVS Caremark and other sizable plans aim to expand the client base.

Regarding regulatory risk, Omada's work has primarily been with commercially insured individuals. As of the end of 2024, they hold 14% of the self-insured market, 9% of the fully insured market, and 1% of Medicare Advantage. While Medicare Advantage is a small but growing portion of revenue, it represents a significant future growth opportunity. Omada has not been subject to the same market fluctuations as companies reliant on exchange subsidies.

Competitive Advantage and Digital Health 2.0

To skeptical investors who might favor larger, more integrated players, Duffy highlights that Omada is a provider that contracts through claims, operating outside of employer wellness budgets and without the capex of physical clinics. This is characterized as Digital Health 2.0, where companies provision care, prove its efficacy through publications, and deliver it through a complex blend of people, technology, and hardware. This operational intricacy and scale of problem-solving differentiate Omada from earlier software-only solutions.

The Role of AI and Human Connection

AI is a significant focus for Omada, enabling capabilities that were once just dreams. Member-facing AI features include food photo analysis for macronutrient tracking and support in motivational interviews. However, Omada emphasizes that AI complements, rather than replaces, the human element. The "art" of healthcare lies with people, while AI provides the "science."

Duffy stresses the importance of human accountability. Members feel accountable to other humans, not just large language models. This human connection, where a coach gets to know the member, their goals, and provides personalized support, is crucial for adherence and motivation, akin to the relationship with a personal trainer. The blend of AI sophistication and human compassion is seen as the future, where care teams leverage AI to delegate tasks and focus on higher-value interactions.

Hardware and Technology Integration

Omada's hardware, including scales, blood pressure cuffs, and glucometers, is designed for ease of use ("Sean Duffy's mom test") with cellular connectivity to ensure automatic setup. The integration of this hardware with software, care plans, care teams, and content creates a full-stack experience that drives member stickiness and clinical outcomes. The data generated by these devices, when combined with human insight, is essential for executing care plans and improving outcomes, addressing the limitations of data alone in solving the chronic disease epidemic.

Instilling Culture and Values

Omada is building a values-driven organization. Core values like "cultivate trust," "seek context," "act boldly," and "remember why we're here" are embedded into performance and hiring processes. In healthcare, where trust is paramount, these internal values permeate externally, influencing customer perception, retention, and growth.

Vision for the Future of American Healthcare

Duffy's ultimate vision is for Omada to have brought the care model that chronic care should have always had to the American healthcare system. This means a default expectation of tailored, longitudinal care for specific conditions, moving beyond the limitations of fee-for-service and existing operational models. He hopes Omada will shift the paradigm from exceptional care to the rule.

Personal Interest: FPV Drones

In his free time, Duffy enjoys building and flying first-person view (FPV) drones, a hobby that began during COVID-19. This involves assembling components, soldering, and programming, offering a fun, hands-on experience akin to playing a video game with real-world consequences. It serves as a stress reliever and a way to engage with a technical hobby.